Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Industry News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Industry News
Celgene Dips Out of Deals Ahead of Mega-Merger 6/19/2019
BeiGene and SpringWorks Announce the Formation of JV MapKure 6/18/2019
China's Fosun Mulls Joint Bid for Bayer's Animal Health Business 6/18/2019
Mycovia, Jiangsu Hengrui to Develop and Commercialize Antifungal ... 6/18/2019
CASI Pharmaceuticals Acquires Worldwide Rights To Commercialize a... 6/17/2019
Deciphera Pharma and Zai Lab Announce Exclusive License Deal for ... 6/17/2019
Theravance and Mylan Expand YUPELRI (revefenacin) Deal to include... 6/14/2019
Sinovant Granted Chinese Clinical Trial Approval for Lefamulin 6/14/2019
Solvotrin and Fosun Agree to China Deal for Iron Deficiency Drug 6/14/2019
111 Enters Strategic Partnership Deal with Tong Ren Tang Tech to ... 6/13/2019
SEC probes Siemens, GE, Philips in alleged China medical equipmen... 6/13/2019
Chinese Biopharma Firm Epimab Bags $74m Series B 6/13/2019
Parexel Teams with CLARINESS to Enhance Patient Access and Engage... (free) 6/13/2019
R2 Dermatology Signs Exclusive Asia-Pacific Distribution Agreemen... 6/13/2019
Tessa Launches China JV in $120M Deal 6/13/2019
Zai Lab Approved to Commercialize ZEJULA (Niraparib) in Macau for... 6/13/2019
Oncologie Closes an $80M Series B Financing for Clinical-Stage Pi... (free) 6/11/2019
Exscientia and GT Apeiron Enter A Multi-target AI Drug Discovery ... 6/11/2019
Everest Acquires China Rights to Kidney Disease Drug from Callidi... 6/10/2019
BioMarin's Vimizim Approved in China for Rare Genetic Malady 6/6/2019
Achaogen Disposes Most Assets to Cipla and Qilu thru Auction 6/6/2019
Frontage Holdings Announces Successful IPO on the HKEx (free) 6/6/2019
China Reportedly to Probe Accounting of 77 Major Pharma Companies... 6/5/2019
Financial-related Company News in Brief 5/31/2019
Predicine Partners with FMD for Biomarker-Driven Trials and Regul... 5/31/2019
Hansoh Pharma to Initiate $1 Billion Hong Kong IPO 5/31/2019
Pfizer Upjohn Sets Up Global Headquarters in Shanghai 5/30/2019
Teva and NuanceBiotech Launch Non-Hodgkin Lymphoma Drug Treanda i... 5/30/2019
Benchmark Signs Definitive Investment Agreement with Zhejiang Yat... (free) 5/30/2019
Luye Pharma's Rykindo NDA Filing Accepted by the U.S. FDA 5/30/2019
Page:1/18    Total number of articles:521  :[1][2][3][4][5][>>][End]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links